Institutional Stem Cell Research Oversight (ISCRO)
The mission of the ISCRO is to review research involving human embryonic stem cells, human totipotent or pluripotent cells, human pluripotent stem cell lines, human neural and gonadal progenitor stem cells or other somatic tissues for stem cell research (excluding cells that remain restricted in tissue potential and are not known to possess totipotent or pluripotent potential). Documentation of the provenance of the material(s) is required.
NOTICE: A new NIH policy has taken effect with regard to the HeLa cell line and its derivatives, specifically relating to genome information. An NIH announcement regarding the policy can be found here: http://www.nih.gov/news/health/aug2013/nih-07.htm. While this new policy does not at all restrict use of HeLa cells, it does restrict use of any genomic sequence data from these cells. For complete details, please visit the NCBI HeLa Cell Genome Sequencing Studies website.
Basic ISCRO Review and Approval Procedure
- The principal investigator* must complete the application form to submit proposed research protocols for review to the committee Chair.
- The proposed protocols are reviewed to ensure that the science is appropriate and ethical according to accepted stem cell guidelines (NAS and ISSCR) and that all personnel working with stem cells receive ethical training in their use.
- The approval period is for three years, subject to annual approvals at the end of years one and two.
- All modifications to the approved protocol must be submitted using the Renewal/Update form and re-approved in writing by the ISCRO prior to implementation.
* The investigator who is primarily responsible for the conduct of the research. Only faculty or staff members may be Principal Investigators. All non-faculty researchers are properly characterized as Co-Investigators.
ISCRO Proposal Review Procedure
Institutional Official (IO)
Wolf von Maltzahn, Ph.D.
Associate Vice President for Research (518) 276-4873; email@example.com